Healthcare

Pfizer's recent $7 billion acquisition of biotechnology firm Metsera has triggered a wave of market skepticism rather than celebration. The...

While numerous real estate investment trusts focused on healthcare face ongoing structural challenges, LTC Properties is demonstrating unexpected resilience. The...

Intellia Therapeutics is confronting one of its most severe market downturns following a cascade of negative developments that have severely...

Baxter International Inc. finds its equity trading near annual lows as the medical technology company contends with a confluence of...

The diagnostic imaging sector is witnessing an aggressive expansion campaign from RadNet, whose latest strategic purchase of River Radiology in...

The animal health sector's former high-flyer is confronting significant growth challenges. With market analysts systematically lowering their projections, the equity...

Biogen has secured two significant advancements that could reinvigorate the biotechnology company's growth trajectory. Recent developments include a streamlined treatment...

UnitedHealth Group is facing a significant withdrawal of institutional support despite the healthcare giant's efforts to bolster investor confidence through...

UnitedHealth Group finds itself balancing conflicting signals as the healthcare behemoth projects stronger financial performance for 2025 while simultaneously facing...

Vapotherm has achieved a significant regulatory milestone with the U.S. Department of Defense granting operational approval for its HVT® 2.0...